Two approaches have emerged for creating libraries of compounds for use in biological screening assays for drug discovery — fragment-based ligand design and diversity-oriented synthesis. Advocates of each approach discuss their favoured strategy.
- Philip J. Hajduk
- Warren R. J. D. Galloway
- David R. Spring